Clinical trials
Phase 3 Infections trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2019 | 1 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Recruiting | 3 |
| Unknown status | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ViiV Healthcare | 12 |
| Assistance Publique - Hôpitaux de Paris | 4 |
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| Janssen-Cilag International NV | 3 |
| Aridis Pharmaceuticals, Inc. | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Cadence Pharmaceuticals | 1 |
| Centre Antoine Lacassagne | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Infections | 38 |
| Acquired Immunodeficiency Syndrome | 11 |
| HIV Infections | 9 |
| COVID-19 | 3 |
| Sepsis | 3 |
| Virus Diseases | 3 |
| Blast Crisis | 2 |
| Burkitt Lymphoma | 2 |
| Coronavirus Infections | 2 |
| Dendritic Cell Sarcoma, Interdigitating | 2 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.